USPTO serial 77781313
OXIMIZE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- ULRICH, NANCY G
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with OXIMIZE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Acne medications; Amino acids for nutritional purposes; Anti-cancer preparations; Anti-cavity dental coating preparations containing fluoride; Anti-infective products for veterinary use; Anti-microbial handwash; Antibacterial substances for medical purposes; Aromatized beverages based on fruit, protein, cordial, sugar and other fluid nutrients, namely, meal replacement drinks for use as a food fillers; Athletes' foot powders; Bacterial and bacteriological preparations for medical or veterinary purposes; Biochemical preparations for medical or veterinary purposes; Biscuits, bread, bread rolls, cakes, cereal products, confectionery, crackers, noodles, fish sauce, relish, sauces, cereal-based snack-foods and prepared dietary items all of which are gluten -free to accommodate special medical and health conditions; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Chewing gum for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary pet supplements in the form of pet treats; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements for controlling cholesterol; Dietary supplements for pets in the nature of a powdered drink mix; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Energy boosting bars for use as a meal substitute; Face creams and cleansers containing benzoyl peroxide for medical purposes, namely, the treatment of acne; Food supplements, namely, anti-oxidants; Herbal supplements; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; Liquid antipruritic; Liquid nutritional supplement; Meal replacement and dietary supplement drink mixes; Meal replacement bars; Medical cleansers for skin and wounds; Medicated chewing gum; Medicated cosmetics; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Mineral nutritional supplements; Multi-vitamin preparations; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutritional drink mix for use as a meal replacement; Nutritional energy bars for use as a meal substitute; Nutritional meal replacement bars for individuals undergoing medical treatments; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Powdered milk for babies; Powdered nutritional supplement drink mix; Pre-moistened medicated towelettes; Preparations for cleansing the skin for medical use; Protein supplements; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Topical analgesics; Veterinary preparations, namely, antioxidants; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin enriched water; Vitamin fortified beverages; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamins and dietary food supplements for animals | ABANDONED | Jul 1, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2016 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| May 12, 2016 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| May 12, 2016 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| May 12, 2016 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Apr 15, 2016 | PC.D | PETITION TO DIRECTOR DISMISSED | — |
| Feb 1, 2016 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 15, 2016 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Jun 30, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2014 | PCDE | PETITION TO DIRECTOR DENIED | — |
| May 5, 2014 | APET | ASSIGNED TO PETITION STAFF | — |
| Mar 27, 2014 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Feb 2, 2012 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Jun 7, 2011 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 5, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 25, 2010 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 19, 2010 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 3, 2010 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Apr 27, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 27, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 24, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 24, 2010 | ALIE | ASSIGNED TO LIE | — |
| Mar 10, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 9, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2009 | NWAP | NEW APPLICATION ENTERED | — |